ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

ClinicalTrials.gov ID: NCT05669664

Public ClinicalTrials.gov record NCT05669664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study of Darolutamide in Combination With Leuprolide Acetate in Hormone-Therapy Naive Recurrent and/or Metastatic Androgen Receptor (AR) Positive Salivary Gland Cancer

Study identification

NCT ID
NCT05669664
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
21 participants

Conditions and interventions

Interventions

  • Biopsy Procedure Procedure
  • Biospecimen Collection Procedure
  • Computed Tomography Procedure
  • Darolutamide Drug
  • Leuprolide Acetate Drug
  • Magnetic Resonance Imaging Procedure

Procedure · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 19, 2023
Primary completion
Apr 10, 2027
Completion
Apr 10, 2027
Last update posted
Nov 9, 2025

2023 – 2027

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine California 92612
Los Angeles General Medical Center Los Angeles California 90033
USC / Norris Comprehensive Cancer Center Los Angeles California 90033
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868
University of California Davis Comprehensive Cancer Center Sacramento California 95817
UCHealth University of Colorado Hospital Aurora Colorado 80045
Emory University Hospital Midtown Atlanta Georgia 30308
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637
UC Comprehensive Cancer Center at Silver Cross New Lenox Illinois 60451
University of Chicago Medicine-Orland Park Orland Park Illinois 60462
UChicago Medicine Northwest Indiana Crown Point Indiana 46307
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748
Memorial Sloan Kettering Bergen Montvale New Jersey 07645
Memorial Sloan Kettering Commack Commack New York 11725
Memorial Sloan Kettering Westchester Harrison New York 10604
Laura and Isaac Perlmutter Cancer Center at NYU Langone New York New York 10016
Memorial Sloan Kettering Cancer Center New York New York 10065
Memorial Sloan Kettering Nassau Uniondale New York 11553
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232
M D Anderson Cancer Center Houston Texas 77030
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112
University of Virginia Cancer Center Charlottesville Virginia 22908
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center Madison Wisconsin 53718
University of Wisconsin Carbone Cancer Center - University Hospital Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05669664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05669664 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →